Lung Cancer TALK: A Review of Data from the IASLC 2020 World Conference on Lung Cancer - Episode 5

WCLC Updates in Locally Advanced NSCLC

March 5, 2021

Stephen Liu, MD, Georgetown Lombardi Comprehensive Cancer Center, Sarah Goldberg, MD, MPH, Yale School of Medicine, Benjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Heather A. Wakelee, MD, Stanford University Medical Center

Key opinion leaders provide insights on chemotherapy and radiotherapy in patients with unresectable, locally advanced non–small cell lung cancer (NSCLC).

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC

EP. 2: WCLC Updates on the Emergence of ADCs in NSCLC

EP. 3: WCLC Updates in Immunotherapy for NSCLC

EP. 4: WCLC Updates in Neoadjuvant Therapy for NSCLC

Now Viewing

EP. 5: WCLC Updates in Locally Advanced NSCLC

EP. 6: WCLC Updates in Small Cell Lung Cancer

Data from the following clinical trial are discussed:

 OA02.03 - Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy in Unresectable, Locally Advanced Stage III NSCLC: KEYNOTE-799